GSK
917 hedge funds and large institutions have $14.4B invested in GSK in 2021 Q4 according to their latest regulatory filings, with 193 funds opening new positions, 319 increasing their positions, 247 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
917
Holders Change
+127
Holders Change %
+16.08%
% of All Funds
14.16%
Holding in Top 10
19
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+46.15%
% of All Funds
0.29%
New
193
Increased
319
Reduced
247
Closed
52
Calls
$624M
Puts
$233M
Net Calls
+$391M
Net Calls Change
+$227M
Top Buyers
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
$51.1M |
| 2 |
Capital International Investors
Los Angeles,
California
|
$843M |
| 3 |
Two Sigma Advisers
New York
|
$39.9M |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
$171M |
| 5 |
Two Sigma Investments
New York
|
$84.8M |
